vs
Forestar Group Inc.(FOR)与MADRIGAL PHARMACEUTICALS, INC.(MDGL)财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Forestar Group Inc.的1.2倍($321.1M vs $273.0M),Forestar Group Inc.净利率更高(5.6% vs -18.2%,领先23.9%),MADRIGAL PHARMACEUTICALS, INC.同比增速更快(210.8% vs 9.0%),MADRIGAL PHARMACEUTICALS, INC.自由现金流更多($-133.8M vs $-157.1M)
福雷斯特集团是一家住宅地块开发企业,总部位于得克萨斯州阿灵顿,业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内,该公司交付了11518块住宅地块,目前在纽约证券交易所上市,自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
本公司是一家美国生物制药企业,成立于2002年,专注于研发新型合成胆汁酸类似物,可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病,以及胆汁酸性腹泻等肠道疾病。
FOR vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.2倍
$273.0M
营收增速更快
MDGL
高出201.7%
9.0%
净利率更高
FOR
高出23.9%
-18.2%
自由现金流更多
MDGL
多$23.3M
$-157.1M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $273.0M | $321.1M |
| 净利润 | $15.4M | $-58.6M |
| 毛利率 | 20.1% | — |
| 营业利润率 | 7.6% | -18.6% |
| 净利率 | 5.6% | -18.2% |
| 营收同比 | 9.0% | 210.8% |
| 净利润同比 | -6.7% | 1.4% |
| 每股收益(稀释后) | $0.30 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FOR
MDGL
| Q4 25 | $273.0M | $321.1M | ||
| Q3 25 | $670.5M | $287.3M | ||
| Q2 25 | $390.5M | $212.8M | ||
| Q1 25 | $351.0M | $137.3M | ||
| Q4 24 | $250.4M | $103.3M | ||
| Q3 24 | $551.3M | $62.2M | ||
| Q2 24 | $318.4M | — | ||
| Q1 24 | $333.8M | $0 |
净利润
FOR
MDGL
| Q4 25 | $15.4M | $-58.6M | ||
| Q3 25 | $86.9M | $-114.2M | ||
| Q2 25 | $32.9M | $-42.3M | ||
| Q1 25 | $31.6M | $-73.2M | ||
| Q4 24 | $16.5M | $-59.4M | ||
| Q3 24 | $81.5M | $-107.0M | ||
| Q2 24 | $38.7M | — | ||
| Q1 24 | $45.0M | $-147.5M |
毛利率
FOR
MDGL
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | 96.7% | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
营业利润率
FOR
MDGL
| Q4 25 | 7.6% | -18.6% | ||
| Q3 25 | 16.9% | -39.7% | ||
| Q2 25 | 11.2% | -22.2% | ||
| Q1 25 | 11.6% | -57.8% | ||
| Q4 24 | 8.7% | -64.8% | ||
| Q3 24 | 19.7% | -187.1% | ||
| Q2 24 | 16.2% | — | ||
| Q1 24 | 17.6% | — |
净利率
FOR
MDGL
| Q4 25 | 5.6% | -18.2% | ||
| Q3 25 | 13.0% | -39.8% | ||
| Q2 25 | 8.4% | -19.9% | ||
| Q1 25 | 9.0% | -53.4% | ||
| Q4 24 | 6.6% | -57.5% | ||
| Q3 24 | 14.8% | -172.0% | ||
| Q2 24 | 12.2% | — | ||
| Q1 24 | 13.5% | — |
每股收益(稀释后)
FOR
MDGL
| Q4 25 | $0.30 | $-2.55 | ||
| Q3 25 | $1.70 | $-5.08 | ||
| Q2 25 | $0.65 | $-1.90 | ||
| Q1 25 | $0.62 | $-3.32 | ||
| Q4 24 | $0.32 | $-2.50 | ||
| Q3 24 | $1.59 | $-4.92 | ||
| Q2 24 | $0.76 | — | ||
| Q1 24 | $0.89 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $198.7M |
| 总债务越低越好 | $793.2M | $339.9M |
| 股东权益账面价值 | $1.8B | $602.7M |
| 总资产 | $3.2B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.56× |
8季度趋势,按日历期对齐
现金及短期投资
FOR
MDGL
| Q4 25 | $211.7M | $198.7M | ||
| Q3 25 | $379.2M | $295.7M | ||
| Q2 25 | $189.2M | $186.2M | ||
| Q1 25 | $174.3M | $183.6M | ||
| Q4 24 | $132.0M | $100.0M | ||
| Q3 24 | $481.2M | $232.7M | ||
| Q2 24 | $359.2M | — | ||
| Q1 24 | $416.2M | $622.5M |
总债务
FOR
MDGL
| Q4 25 | $793.2M | $339.9M | ||
| Q3 25 | $802.7M | $339.8M | ||
| Q2 25 | $872.8M | $118.4M | ||
| Q1 25 | $872.5M | $118.0M | ||
| Q4 24 | $806.8M | $117.6M | ||
| Q3 24 | $706.4M | $117.1M | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | $116.1M |
股东权益
FOR
MDGL
| Q4 25 | $1.8B | $602.7M | ||
| Q3 25 | $1.8B | $625.7M | ||
| Q2 25 | $1.7B | $696.0M | ||
| Q1 25 | $1.6B | $710.6M | ||
| Q4 24 | $1.6B | $754.4M | ||
| Q3 24 | $1.6B | $777.2M | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | $850.8M |
总资产
FOR
MDGL
| Q4 25 | $3.2B | $1.3B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.1B | $1.0B | ||
| Q1 25 | $3.0B | $996.6M | ||
| Q4 24 | $3.0B | $1.0B | ||
| Q3 24 | $2.8B | $1.1B | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.6B | $1.1B |
负债/权益比
FOR
MDGL
| Q4 25 | 0.44× | 0.56× | ||
| Q3 25 | 0.45× | 0.54× | ||
| Q2 25 | 0.52× | 0.17× | ||
| Q1 25 | 0.53× | 0.17× | ||
| Q4 24 | 0.50× | 0.16× | ||
| Q3 24 | 0.44× | 0.15× | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $-133.8M |
| 自由现金流率自由现金流/营收 | -57.5% | -41.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | -10.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.0M | — |
8季度趋势,按日历期对齐
经营现金流
FOR
MDGL
| Q4 25 | $-157.0M | $-133.5M | ||
| Q3 25 | $256.3M | $79.8M | ||
| Q2 25 | $15.8M | $-47.1M | ||
| Q1 25 | $-19.8M | $-88.9M | ||
| Q4 24 | $-450.0M | $-104.5M | ||
| Q3 24 | $119.2M | $-67.0M | ||
| Q2 24 | $-61.7M | — | ||
| Q1 24 | $-59.2M | $-149.2M |
自由现金流
FOR
MDGL
| Q4 25 | $-157.1M | $-133.8M | ||
| Q3 25 | $255.6M | $79.0M | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | — | $-104.7M | ||
| Q3 24 | $118.4M | $-67.8M | ||
| Q2 24 | $-62.3M | — | ||
| Q1 24 | $-59.8M | $-149.5M |
自由现金流率
FOR
MDGL
| Q4 25 | -57.5% | -41.7% | ||
| Q3 25 | 38.1% | 27.5% | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | — | -101.3% | ||
| Q3 24 | 21.5% | -109.0% | ||
| Q2 24 | -19.6% | — | ||
| Q1 24 | -17.9% | — |
资本支出强度
FOR
MDGL
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.1% | 1.3% | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率
FOR
MDGL
| Q4 25 | -10.19× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | -0.63× | — | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |